News that Merck’s antiviral drug molnupiravir had successfully treated coronavirus patients in clinical trials set off celebrations around the world.
Headlines trumpeted claims that we might finally have a truly effective pill that prevents severe COVID in people who get infected. Shares of Merck stock jumped. One German doctor called molnupiravir “a game changer.”i
A trial involving about 700 people with mild to moderate cases of COVID-19 showed that the medication cut in half the risk of hospitalization.… Read More